Nita J. Maihle
Affiliate Faculty
Department:
SOM-Medicine
Email:
nmaihle@umc.edu
Work Phone:
(601) 984-5350
Biography
Dr. Nita Maihle is an experienced cancer biologist who has devoted her career to developing a better understanding of what causes cancer, and to applying this information to improved methods for the early detection, prevention, and treatment of cancer. Over the past three decades, Dr. Maihle and her colleagues have discovered that the signals that cause cancer cells to grow are different from the signals that cause normal cells to grow. These “short circuits” in cancer cells can be targeted to specifically stop cancer cells from growing. New drugs targeting these cancer cell short circuits, drugs such as Herceptin and Gleevec, are some of the most cutting-edge, effective, and specific agents used in the treatment of cancer patients today. Studies in Dr. Maihle’s laboratory are focused on the discovery of disruptive innovations in the rapidly emerging field of precision medicine: innovations that will allow the more efficient coupling of these new, biologically-targeted therapeutics to the right cancer patients, through the development and application of biochemical and molecular diagnostics.
These short circuits in cancer cells result in a molecular signature that is unique to the cancer cell. Dr. Maihle’s laboratory has developed exquisitely sensitive biochemical assays that may one day be useful in detecting cancer cells anywhere in the body using a simple blood test to detect a tumor long before it is clinically detectable. Such early detection would allow even currently available treatments to be more effective— alleviating much human suffering. Dr. Maihle is strongly committed to the clinical translation of these basic research discoveries.
In addition, Dr. Maihle has served as a mentor and role model for many successful students, residents, fellows, and visiting professors, and has been particularly active as an advocate for women and other underrepresented individuals in the biomedical sciences. She serves in a leadership capacity for numerous interdisciplinary cancer research organizations throughout the country, and also for several national research funding organizations.
Education
| Yale University, MA, Medicine | 2005 |
| Case Western Reserve School of Medicine, Postdoc Fellowship, Tumor Biology | 1989 |
| Cold Spring Harbor Laboratory, Postdoc Fellowship, Tumor Virology | 1984 |
| NCI-FCRF, Postdoc Fellowship, Tumor Virology | 1984 |
| Albert Einstein College of Medicine, PhD, Biomedical Sciences | 1983 |
| Albert Einstein College of Medicine, MS, Biomedical Sciences | 1981 |
| Miami University, MS, Biology | 1977 |
| Miami University, BA, Biology/Botany | 1976 |
Current Positions
| Professor, School of Medicine | 10/2019 - Present |
| The University of Mississippi Medical Center Jackson, Mississippi 39216 | |
Academic Appointments or Other Previous Appointments
| Professor, Medical College of Georgia, School of Medicine, Department of Biochemistry | 08/2013 - 09/2018 |
| Professor, Yale University, School of Medicine, Department of Pathology | 08/2003 - 07/2013 |
| Professor, Mayo Clinic, School of Medicine | 07/1999 - 07/2003 |
| Associate Professor, Mayo Clinic, School of Medicine, Department of Biochemistry | 07/1993 - 06/1999 |
| Assistant Professor, Mayo Clinic, School of Medicine, Department of Biochemistry | 04/1989 - 06/1993 |
Sponsored Program Funding
| Extramural, The Ovarian Cancer Academy 2020-2025, Dept of Defense | 09/2020 - 09/2025 |
| Extramural, Healthy Aging Initiative, Joe W. and Dorothy Dorsett Brown Foundation | 01/2020 - 12/2020 |
| Extramural, Colleen's Dream Ovarian Cancer Research Award, Colleen's Dream Ovarian Cancer Research Foundation | 01/2020 - 12/2020 |
| Extramural, NIH/NSF ASCB Minority Affairs Committee Faculty Research and Education Development Program Mentor Award, NIH/NSF | 07/2018 - 06/2019 |
| Extramural, NIH/NSF ASCB Minority Affairs Committee Faculty Research and Education Development Program Mentor Award, NIH | 07/2017 - 06/2018 |
| Extramural, NIH/NSF ASCB Minority Affairs Committee Faculty Research and Education Development Program Mentor Award, NIH | 07/2016 - 06/2017 |
| Extramural, The Ovarian Cancer Academy 2020-2015: A Data-Driven Learning, Department of Defense | 10/2015 - 09/2020 |
| Extramural, National Institute of Child Health and Development 'Women's Reproductive Health Research', NICH | 07/2015 - 06/2020 |
| Extramural, National Science Foundation ASCB Minority Affairs Committee Faculty Research and Education Development Program Mentor Award, NSF | 07/2015 - 06/2016 |
| Extramural, USAMRDC Ovarian Cancer Research Program 'Ovarian Cancer Academy Dean' Award, USAMRDC | 07/2015 - 06/2020 |
| Intramural, Combining Models to Overcome Trastuzumab Resistance in Breast Cancer, Augusta Univ Cancer Center Basic Science Award | 10/2014 - 10/2015 |
| Extramural, National Institute of Heart, Lung, and Blood 'Program to Increase Diversity among Individuals Engaged in Health-related Research', NICH | 10/2014 - 09/2018 |
| Extramural, National Cancer Institute 'TIES Translational Research Network Consortium', NCI | 09/2013 - 08/2018 |
| Extramural, Development of Serum sEGFR as a New Biomarker in a Mouse Model of Lung CA, Labrecque Foundation for Lung Cancer Research | 03/2012 - 02/2014 |
| Extramural, "A Preclinical Study of p45-sHER3: A Metastasis Factor in Melanoma", Harry J. Lloyd Charitable Foundation | 12/2011 - 11/2014 |
| Intramural, Murine sEGFR: a New Biomarker in Lung Cancer, Yale Cancer Center | 06/2011 - 08/2011 |
| Extramural, Susan G. Komen for the Cure Foundation Award, Komen | 01/2011 - 12/2016 |
| Extramural, Serum sEGFR in Patients Treated with Lapatinib: A Search for Prognostic Factors, GOG | 04/2010 - 03/2011 |
| Extramural, Glioma Therapeutics Glioma Pathogenesis-related Protein, NIH SBIR [R43] | 01/2009 - 12/2010 |
| Extramural, Novel Mechanisms of EGFR Gene Expression Regulation, NIH NIGMS [SC2] | 08/2008 - 09/2011 |
| Intramural, A Novel Breast Cancer Biomarker, Yale Cancer Center - Swebilius Fund | 07/2008 - 06/2009 |
| Extramural, Overcoming Herceptin Resistance in Ovarian Cancer, Marsha Rivkin Center for Ovarian Cancer Research | 07/2008 - 06/2010 |
| Extramural, sErbB3: A Novel Ovarian Cancer Prognostic Marker, Marsha Rivkin Center for Ovarian Cancer Research | 07/2008 - 06/2010 |
| Extramural, Overcoming Herceptin Resistance in Ovarian Cancer, Komen | 07/2008 - 10/2011 |
| Extramural, Inhibitory Potential of sErbB3, Pardee Foundation | 05/2006 - 04/2007 |
| Extramural, Overcoming Herceptin Resistance, Ovarian Cancer Research Fund | 01/2006 - 12/2006 |
| Extramural, Overcoming Resistance to Herceptin, The Ladies Auxiliary Veterans of Foreign Wars | 06/2005 - 05/2006 |
| Extramural, Pharmacogenomics of EGFR/HER Receptor Expression in Cancer, Pfizer Visiting Professorship Program | 12/2003 - 10/2004 |
| Extramural, Sensitivity and Specificity of an sEGFR ALISA in the Detection of Ovarian Cancer, Marsha Rivkin Center Pilot Study Award | 01/2003 - 12/2003 |
| Extramural, EGF Receptor Blockade in Endometrial Cancer, National Cancer Institute [R01] | 07/2002 - 06/2007 |
| Extramural, p60 sErbB1: A Negative Regulator of EGF-Stimulated Breast Carcinoma Cell Growth, U. S. Army Medical Research Command Predoctoral Fellowship Award | 09/2000 - 08/2003 |
| Extramural, National Ovarian Cancer Early Detection Network, NIH/NCI [U01] | 04/2000 - 03/2005 |
| Extramural, Development of an Assay for Serum sErbB1 p60: Pilot Studies in Breast Cancer Patients, Prospect Creek Foundation | 01/2000 - 12/2001 |
| Extramural, Development of an sErbB ALISA: Pilot Studies in Breast Cancer Patients, Komen | 01/2000 - 12/2001 |
| Intramural, Circulating sErbB1, sErbB2, and CA-125 Levels as Diagnostic and Prognostic Biomarkers in Women with Epithelial Ovarian Cancer, Mayo Foundation Clinician Investigator Award | 06/1999 - 05/2000 |
| Extramural, Serologic sErbB1 in Healthy Women, NIH/NCI [R03] | 06/1999 - 05/2001 |
| Extramural, Serologic sErbB2 Levels as Diagnostic Tumor Biomarkers, NIH/NCI [R21] | 06/1999 - 05/2001 |
| Extramural, Circulating sErbB1/2 Levels as Breast Cancer Biomarkers, Friends You Can Count On Foundation | 01/1999 - 12/2000 |
| Extramural, sErbB1 and sErbB2 Receptor Expression Patterns in Women with Breast Diseases, Prospect Creek Foundation | 01/1999 - 12/2000 |
| Extramural, Randomized Phase II Trial of Irinotecan (CPT-II) in Patients with Refractory Metastatic Breast Cancer, Pharmacia and Upjohn | 10/1998 - 12/1999 |
| Extramural, Randomized Phase II Trial of Paclitaxel, Carboplatin and rhuMAbHER-2 (Herceptin) as First-line Chemotherapy in Patients with Metastatic Breast Cancer Who Overexpress HER-2, Genentech | 10/1998 - 09/2000 |
| Extramural, EREs in the Amphiregulin Gene, NIH/NCI [K01] | 08/1998 - 07/2002 |
| Extramural, Biology of Cancer: A Predoctoral Training Program, NIH/NCI [T32] | 07/1998 - 06/2003 |
| Extramural, Soluble ErbB1 Molecules as Tumor Biomarkers, NIH/NCI [K07] | 07/1998 - 06/2003 |
| Extramural, Mechanisms of Ligand-independent EGFR Signaling in Human Glioblastomas, Fraternal Order of Eagles Cancer Research Fund | 04/1998 - 09/1999 |
| Extramural, Modulation of Heregulin Mediated Breast Carcinoma Cell Growth by Soluble ErbB3, NIH/NCI [R21] | 10/1997 - 09/1998 |
| Extramural, Randomized Phase II Study of Docetaxel and Doxorubicin/ Cyclophosphamide (AC) in Patients with Metastatic Breast Cancer, Rhone-Poulenc Rorer Fund | 10/1997 - 12/1998 |
| Extramural, Development of a New Model to Study the Interactions of Obesity on the Development of Breast Cancer, U. S. Army Medical Research Command | 09/1997 - 08/2000 |
| Extramural, Differential Expression of Alternative Transcripts from the Human Epidermal Growth Factor Receptor Gene in Normal and Malignant Ovarian Tissues, Fraternal Order of Eagles Cancer Research Fund | 05/1997 - 04/1998 |
| Extramural, sErbB1 and sErbB2 Receptor Expression Patterns in Women with Breast Diseases, Prospect Creek Foundation | 01/1997 - 12/2000 |
| Extramural, IL-6 and sIL-6 Growth Inhibition of Breast Cancer Cells, NIH [R01] | 04/1996 - 03/2000 |
| Extramural, IL-6 and sIL-6R Growth Inhibition of Breast Carcinoma Cells, Komen | 01/1996 - 12/1997 |
| Extramural, Amphiregulin in Prostate Cancer, Pardee Foundation | 01/1996 - 12/1997 |
| Extramural, Mechanisms of Human sErbB1 Inhibition of Transformation, NIH [NRSA] | 07/1995 - 07/1997 |
| Extramural, Development of a Breast Cancer Research Program at Mayo, NIH/NCI [P20] | 12/1994 - 11/1998 |
| Extramural, Biology of Breast Cancer: A Predoctoral Training Program, U. S. Army Medical Research Command | 09/1994 - 08/1998 |
| Extramural, Tamoxifen Effects on Interleukin-6 Pathways in Human Breast Cancer, NIH/NCI [U10 Supplement] | 06/1994 - 05/1995 |
| Extramural, Interleukin 6 Growth Inhibition of Breast Carcinoma Cells, Fraternal Order of Eagles' Cancer Research Fund | 05/1994 - 04/1995 |
| Extramural, Associate Director for Basic Sciences/Cancer Research, NIH/NCI-Sponsored Mayo Cancer Center [P30 - CCSG] | 01/1994 - 12/1998 |
| Extramural, Truncated c erbB Receptors in Ovarian Carcinomas, NIH/NCI [NRSA] | 01/1993 - 12/1993 |
| Extramural, Tissue specific Tumorigenesis by the c erbB Oncogene, NIH/NCI [K11] | 09/1992 - 08/1997 |
| Extramural, Mechanisms of Ligand-Independent Transformation by c erbB, NIH/NCI [K11] | 09/1992 - 08/1994 |
| Extramural, Truncated c erbB Receptors in Women with Ovarian Cancer, NIH [R01] | 08/1992 - 07/1997 |
| Extramural, Growth Factors and Cancer Program, NIH/NCI-Sponsored Mayo Cancer Center [P30 - CCSG] | 03/1992 - 02/1997 |
| Extramural, Characterization of a Novel c-erbB Related Transcript, Fraternal Order of Eagles' Cancer Research Fund | 05/1991 - 04/1992 |
| Extramural, Tissue-Specific Oncogenesis Mediated by c-ErbB, NIH/NCI [R01] | 12/1989 - 12/1994 |
Publications
Journal Article | |
| Gibert, Y and Maihle, NJ Agnostic Cancer Immunotherapy: Fact of Fiction? Endocrinology and Metabolic Res. SI.02-01-02; 2020 | 2020 |
| Zhou YY, *Simmons J, Jordan CD, Sonbol MB, Maihle NJ, and Tang SC Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Retrospective Analysis. Clinical Breast Cancer Clin Breast Cancer. 19(5):354-362.37. 2019 | 2019 |
| Maihle NJ, Levine DA, Dhillon K, Armstrong DK Introduction: The 12th Biennial Rivkin Center Ovarian Cancer Research Symposium Int J Gyn Cancer. 29(2); 2019 | 2019 |
| Eisa N, Jilani K, Kashish K, Redd P, Lu S, Bougrine O, Sater H, Patwardha C, *Shull A, Shi H, Horuzsko A, Lui K, Elsherbiny N, Eissa L, Mamdouh M, Horuzsko A, Bollag M, Maihle NJ, Roig J, Korkaya H, Chadli A The co-chaperone UNC45A is essential for the expression of mitotic kinase NEK7 and tumorigenesis J Biol Chem, 294(14): 5246-5260; 2019 | 2019 |
| Yu X, Ghamande S, Liu H, Xue L, Zhao S, Tan W, Zhao L, Tang S, Wu D, Korkaya, H, Maihle NJ, Liu, H-Y Targeting EGFR/HER2/HER3 with Three-in-One aptamer/siRNA chimera confers superior anti-tumor activity in HER2 positive breast cancer Molecular Therapeutics Nucl Acids; 10:317-330; 2018 | 2018 |
| NITA J. MAIHLE and WILL H. BLACKWELL, JR. A SYNOPSIS OF NORTH AMERICAN CORISPERMUM (CHENOPODIACEAE) SIDA, Contributions to Botany Vol. 7, No. 4 (DECEMBER 1978), pp. 382-391 | |
Abstracts | |
| Taylor, Thomas N, Maihle, Nita J, Hills, Len V Morphological and ultrastructural features of Nikitinsporites canadensis chaloner, a devonian megaspore from the frasnian of canada Review of Palaeobotany and Palynology Volume 30, 1980, Pages 89-99 | |
| H.-J. Kung N. J. Maihle Molecular Basis of Oncogenesis by Non-Acute Avian Retroviruses In: De Boer G.F. (eds) Avian Leukosis. Developments in Veterinary Virology, vol 4. Springer, Boston, MA | |
| Salisbury, J.L., Swanson, J.A., Floyd, G.L., Maihle, NJ Ultrastructure of the flagellar apparatus of the green algaTetraselmis subcordiformis Protoplasma March 1981, Volume 107, Issue 1–2, pp 1–11 | |
| Nita J. Maihle, Jacqueline M. Lafky, Andre T. Baron, Cecelia H. Boardman, Tammy M. Greenwood, Trace A. Christensen, Jill L. Reiter, Elsa M. Cora, Hakjoo Lee, Vera Jean Suman, David A. Fishman, Edith A. Perez, Karl C. Podratz EGF receptor/ErbB isoforms as serum biomarkers in breast and ovarian cancer Journal of Clinical Ligand Assay Volume 25 Pages 57-60 Published - Mar 2002 | |
| Kimberly Leslie, Michael Sill, Kathleen Darcy, Andre Baron, Jason Wilken, Andrew Godwin, Linda Cook, Russell Schilder, Jeanne Schilder and Nita Maihle Abstract #LB-134: Prognostic value of serum sEGFR and EGFR mutations in a phase II trial of gefitinib (Iressa®, ZD1839) in women with endometrial cancer AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO | |
Book Chapter | |
| Maihle NJ Cell Receptors Encyclopedia of Human Biology Volume 2 Pages 557-560 | |
| Lafky JM, Greenwood TM, Baron AT, Boardman CH, Cora EM, Maihle NJ Soluble ErbB Receptors [sEGFR/sErbBs]: Serum Biomarkers in Breast and Ovarian Cancer Tumor Markers: Physiology, Pathobiology, Technology and Clinical Applications Chapter 37 Pages 427-431 | |
Presentations
| Poster Presentation, Development and characterization of a chimeric siRNA-aptamer with inhibitory activity in HER3+ cells, SGO 50th Annual Meeting, Honolulu, HI | 03/2019 |
| State/Local Invited Seminars/Lectures, UMMC, Jackson, MS | 06/2018 |
| Regional Invited Seminars/Lectures, UPMC Cancer Center, Pittsburgh, PA | 09/2017 |
| State/Local Invited Seminars/Lectures, UCONN Health Sciences Cancer Center, Farmington, CT | 08/2017 |
| National and International Invited Seminars/Lectures, ASCB/NSF FRED Program Mentoring Workshop, Seattle, WA | 07/2017 |
| Regional Invited Seminars/Lectures, Fred Hutchinson Cancer Center, Seattle, WA | 07/2017 |
| Poster Presentation, The function of sHER3, an endogenous inhibitor of neuregulin signaling, is required by tenascin C, ASCO Annual Meeting, Chicago, IL | 06/2017 |
| Poster Presentation, PI3K Mutation and Effect of Aspirin Use in Breast Cancer, ASCO Annual Meeting, Chicago, IL | 06/2017 |
| Poster Presentation, Determination of Normative Patterns of Gene Expression Levels and Breast Cancer Risk Biomarkers in Human Breast Milk, AACR Annual Meeting, Washington, DC | 04/2017 |
| State/Local Invited Seminars/Lectures, KUMC Cancer Center, Kansas City, KS | 03/2017 |
| State/Local Invited Seminars/Lectures, UPR Medical Sciences Campus, San Juan, PR | 02/2017 |
| Poster Presentation, The RNA-binding protein with multiple splicing (RBPMS) acts as a tumor suppressor in ovarian cancer, ASCB Annual Meeting, San Francisco, CA | 12/2016 |
| Poster Presentation, The effect of p85-sHER3 on cancer cell growth and migration: requirement for tenascin-C, ASCB Annual Meeting, San Francisco, CA | 12/2016 |
| Poster Presentation, Does rural status impact survival in cervical cancer patients receiving Chemoradiation treated at a single institution?, Georgia Academy of Family Physicians' 2016 Annual Scientific Assembly, Atlanta, GA | 10/2016 |
| Poster Presentation, Determining the risk factors for cardiac toxicity in breast cancer patients receiving radiation, ACP Georgia Chapter, Atlanta, GA | 09/2016 |
| State/Local Invited Seminars/Lectures, UI Medical Center, Indianapolis, IN | 09/2016 |
| State/Local Invited Seminars/Lectures, IU Cancer Center, Bloomington, IN | 09/2016 |
| Poster Presentation, The effect of p85-sHER3 on cancer cell growth and migration: requirement for tenascin-C, ISOBM Annual Congress, Chicago, IL | 09/2016 |
| Regional Invited Seminars/Lectures, ASCB/NSF FRED Program Mentoring Workshop, Chapel Hill, NC | 07/2016 |
| State/Local Invited Seminars/Lectures, 2016 Research Day - Innovation & Biomedical Research: Precision Medicine, USC - Aiken, Aiken, SC | 05/2016 |
| Regional Invited Seminars/Lectures, Federated Biospecimen Sharing Facilitated through TIES' (Information Technology for Cancer Research Session), AACR, New Orleans, LA | 04/2016 |
| Poster Presentation, The plasma concentration of EGFR and overall survival in NSCLC, Annual ASTRO Meeting, San Antonio, TX | 10/2015 |
| Poster Presentation, New method for isoform-specific detection of alternate EGFR isoforms in human placenta demonstrates differential isoform expression across semesters, MCG Medical Scholars Research Day, Augusta, GA | 09/2015 |
| Poster Presentation, Changes in circulating EGFR during Radiotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients, International Association for the Study of Lung Cancer, Denver, CO | 09/2015 |
| State/Local Invited Seminars/Lectures, Cedars Sinai Cancer Center, Los Angeles, CA | 02/2015 |
| State/Local Invited Seminars/Lectures, (for NIH MBRS RISE Program), UPR Medical Sciences Campus, San Juan, PR | 02/2015 |
| Poster Presentation, Balancing destructive and regenerative Epidermal Growth Factor Receptor (EGFR) signals in osteoarthritis, Annual Meeting American College of Rheumatology, Boston, MA | 11/2014 |
| National and International Invited Seminars/Lectures, Interview Skills - Professional Development Workshop (CABTRAC), CABTRAC, Steamboat Springs, CO | 10/2014 |
| National and International Invited Seminars/Lectures, Team-Based Science: How to Build a Successful Translational Research Team - Inaugural Translational Research Workshop, Joint Meeting of the International Congress of Endocrinology and the 96th Annual Meeting of the Endocrine Society (ICE/ENDO 2014), Chicago, IL | 06/2014 |
| Corporate Invited Lecture, Regeneron Pharmaceuticals, Tarrytown, NY | 05/2014 |
| Poster Presentation, sHER3 inhibits proliferation and migration of melanoma-derived cells in a tenascin-dependent manner, AACR Annual Meeting, San Diego, CA | 04/2014 |
| Regional Invited Seminars/Lectures, Center for Cancer Research Grand Rounds, NCI, Bethesda, MD | 04/2014 |
| Invited Symposia, International Ovarian Cancer Symposium, Oklahoma City, OK | 02/2014 |
| Regional Invited Seminars/Lectures, 'Science of Health Care Disparities' (Komen-sponsored Disparities in Breast Cancer Research Training Program Satellite Conference), AACR/Komen | 12/2013 |
| Graduation Lecture, Albert Einstein College of Medicine, Distinguished Alumnus of Year Award Lecturer, Albert Einstein College of Medicine, New York, NY | 05/2013 |
| State/Local Invited Seminars/Lectures, University of Kansas Medical Center Grand Rounds, UK Medical Center, Kansas City, KS | 04/2013 |
| State/Local Invited Seminars/Lectures, Distinguished Alumni Guest Speaker, Miami University, Oxford, OH | 03/2013 |
| Platform Presentations, Precision Medicine: A Vision for the Future of Medicine, Landmark Venture Forum 'Investing for Cures – the Future of Medicine', Landmark Venture Forum, New York, NY | 12/2012 |
| State/Local Invited Seminars/Lectures, Medical College of Georgia, Augusta, GA | 12/2012 |
| Platform Presentations, Landmark Venture Forum 'Investing for Cures' - Future of Medicine (Panelists: Sherry Snyder, CEO - Genzyme, Stephen Chang, VP - NY Stem Cell Foundation, Nita Maihle - Yale Professor & BOD Member, Loring Biologics, Inc.), Landmark Venture Forum, New York, NY | 11/2012 |
| State/Local Invited Seminars/Lectures, University of Pennsylvania, Center for Reproduction and Women's Health, University of Pennsylvania, Philadelphia, PA | 05/2012 |
| State/Local Invited Seminars/Lectures, University of Iowa Medical School Grand Rounds, UI Medical School, Iowa City, IA | 05/2012 |
| National and International Invited Seminars/Lectures, Analogies between HER2 shedding and origin of circulating sEGFR: Serum sEGFR biomarker arises via a fibronectin regulated proteolytic cleavage event, AACR Annual Meeting, Chicago, IL | 03/2012 |
| Convocation Speaker, Van Andel Institute Graduate School, Grand Rapids, MI | 08/2011 |
| Regional Invited Seminars/Lectures, Speaker, Department of Molecular Genetics and Microbiology, State University of NY, Stony Brook, NY | 04/2011 |
| State/Local Invited Seminars/Lectures, Stories of Success - Women in Medicine Symposium, State University of NY, Stony Brook, NY | 04/2011 |
| National and International Invited Seminars/Lectures, Diagnostic and prognostic utility of novel EGFR isoforms in cancer patients, AACR Symposium, Philadelphia, PA | 11/2010 |
| National and International Invited Seminars/Lectures, Plenary Speaker, Ninth Annual AACR International Conference on Frontiers in Cancer Prevention Research, AACR, Philadelphia, PA | 11/2010 |
| Regional Invited Seminars/Lectures, Plenary Speaker, Accelerating Development and Advancing Personalized Therapy: Targeted Cancer Therapy, Arlington, VA | 09/2010 |
| Session Chair, Personalized and Translational Medicine Conference, Boston, MA | 09/2010 |
| Regional Invited Seminars/Lectures, Molecular and Translational Oncology Workshop Cancer Education Consortium for Post-graduate Education, Sanibel, FL | 05/2010 |
| National and International Invited Seminars/Lectures, NCI Stakeholders' Meeting: 'Research Priorities for the Future', NCI, Rockville, MD | 05/2010 |
| Poster Presentation, Combined sEGFR and EGFR expression in human tissues reveals the prognostic potential of comprehensive EGFR isoform analysis, AACR Annual Meeting, Washington, DC | 04/2010 |
| State/Local Invited Seminars/Lectures, Department of Biological Sciences, St John's University, Queens, NY | 04/2010 |
| State/Local Invited Seminars/Lectures, UC Davis Cancer Center, Sacramento CA | 03/2010 |
| State/Local Invited Seminars/Lectures, Lenox Hill Hospital, Department of Pathology, Lenox Hill Hospital, NY, NY | 12/2009 |
| Regional Invited Seminars/Lectures, Canary Foundation "Lung Cancer Program", Canary Foundation, NY, NY | 11/2009 |
| Invited Symposia, University of Cincinnati Medical Center, Cincinnati, OH | 09/2009 |
| National and International Invited Seminars/Lectures, Harvard Macy Leadership in Medicine Workshop, Faculty Scholar, Boston, MA | 06/2009 |
| Regional Invited Seminars/Lectures, Tina Brozman Foundation for Ovarian Cancer Research, Tina Brozman Foundation, NY, NY | 05/2009 |
| State/Local Invited Seminars/Lectures, Molecular Medicine Program, Cornell University, Ithaca, NY | 05/2009 |
| State/Local Invited Seminars/Lectures, Molecular and Translational Oncology Workshop Cancer Education Consortium for Post-graduate Education, Greensboro, GA | 04/2009 |
| National and International Invited Seminars/Lectures, 'Precision Medicine: The Innovator's Prescription' and "HER2 Diagnostics: Lessons Learned", AACR, Denver, CO | 04/2009 |
| Regional Invited Seminars/Lectures, Pfizer Global Research - Women's Leadership Network, Pfizer, Groton, CT | 05/2008 |
| State/Local Invited Seminars/Lectures, Trinity College, HHMI-sponsored Undergraduate Research Program, Trinity College, Hartford, CT | 04/2008 |
| National and International Invited Seminars/Lectures, Innovation and Reform in Clinical Trial Design: Implementation of Biomarkers in Clinical Trial Design, Toronto, ON, CAN | 10/2007 |
| State/Local Invited Seminars/Lectures, Connecticut Technology Council, 2008 Women of Innovation, CT Technology Council, New Haven, CT | 08/2007 |
| State/Local Invited Seminars/Lectures, University of Maryland Medical Center, Molecular Pathology, University of Maryland Medical Center, Baltimore, MD | 06/2007 |
| National and International Invited Seminars/Lectures, Gynecologic Oncology Group, 2007 Semi-Annual Meeting, GOG, San Diego, CA | 01/2007 |
| State/Local Invited Seminars/Lectures, Roswell Park Cancer Institute, Buffalo, NY | 09/2006 |
| State/Local Invited Seminars/Lectures, Albert Einstein College of Medicine, Department of Structural Biology, NY, NY | 06/2006 |
| State/Local Invited Seminars/Lectures, Mount Sinai School of Medicine, Department of Oncological Sciences Lecture Series | 05/2005 |
| Invited Symposia, Lynn Cohen Foundation for Ovarian Research, NY, NY | 04/2005 |
| State/Local Invited Seminars/Lectures, Receptor Biologix Inc., San Francisco, CA | 11/2004 |
| State/Local Invited Seminars/Lectures, Pfizer R & D, Groton, CT | 10/2004 |
| Regional Invited Seminars/Lectures, Cancer Education Consortium, "Cancer and Growth Factor Receptors" and "Testing Cancer for HER2 Expression: Lessons Learned", Cancer Education Consortium, Virginia Beach, VA | 06/2004 |
| State/Local Invited Seminars/Lectures, Third Early Detection Research Network Scientific Workshop, Bethesda, MD | 05/2004 |
| Invited Symposia, North Dakota State University, Women's Health Symposium, North Dakota State University, Fargo, ND | 03/2004 |
| State/Local Invited Seminars/Lectures, Ventana Medical Systems, Tucson, AZ | 03/2004 |
| State/Local Invited Seminars/Lectures, University New Mexico Cancer Center, Albuquerque, NM | 03/2004 |
| National and International Invited Seminars/Lectures, AACR Meet-the-Expert Sunrise Session, "Soluble EGFR/HER Receptors: Form, Function, and Clinical Utility as Serum Biomarkers", AACR, Washington, DC | 07/2003 |
| Invited Symposia, Eppley Visiting Professor of Oncology, Symposium Chair and Lecturer, "Biology of Breast Cancer", Univ Nebraska Medical Center, Omaha, NE | 05/2003 |
| State/Local Invited Seminars/Lectures, Pfizer Global Research and Development (Oncology Division), Pfizer, Groton, CT | 02/2003 |
| National and International Invited Seminars/Lectures, "Colloquium on Protein Structure, Function, and Dynamics: Frontiers in Protein Spectroscopy" Session Chair and Speaker, Ponce, PR | 02/2003 |
| State/Local Invited Seminars/Lectures, Yale School of Medicine, Pathology Grand Rounds, Yale University, New Haven, CT | 02/2003 |
| State/Local Invited Seminars/Lectures, Van Andel Cancer Research Institute, Grand Rapids, MI | 01/2003 |
| National and International Invited Seminars/Lectures, ASCO Molecular Therapeutics Symposium, "Receptor Tyrosine Kinase Inhibitors in the Treatment of Gynecologic Malignancies" (Session Chair and Speaker), ASCO, San Diego, CA | 11/2002 |
| National and International Invited Seminars/Lectures, "Integration of Research and Treatment" 4th Ovarian Cancer Research Symposium, Seattle, WA | 09/2002 |
| State/Local Invited Seminars/Lectures, Robert H. Lurie Cancer Center of Northwestern University and Northwestern Memorial Hospital's Ovarian Cancer Early Detection Conference, Symposium Co-chair and Speaker, Northwestern University, Chicago, IL | 09/2002 |
| State/Local Invited Seminars/Lectures, Fox Chase Cancer Center, Philadelphia, PA | 08/2002 |
| State/Local Invited Seminars/Lectures, Yale University - OBGYN, New Haven, CT | 06/2002 |
| Regional Invited Seminars/Lectures, Session Chair, Molecular Mechanisms Underlying Ovarian Cancer: Implications for Prevention and Treatment, University of Pittsburgh Cancer Institute, Pittsburgh, PA | 05/2002 |
| State/Local Invited Seminars/Lectures, University Utah Medical School - Huntsman Cancer Center, Salt Lake City, UT | 05/2002 |
| Regional Invited Seminars/Lectures, Society for Gynecologic Investigation, Los Angeles, CA | 03/2002 |
| Regional Invited Seminars/Lectures, Gordon Research Conference, "New Frontiers in Cancer Detection and Diagnosis", Gordon Research Conference, Ventura Beach, CA | 03/2002 |
| State/Local Invited Seminars/Lectures, Oklahoma University Health Sciences Center, Department of Biochemistry and Molecular Biology, Norman, OK | 02/2002 |
| State/Local Invited Seminars/Lectures, University of Illinois at Chicago Medical School, Department of Pharmaceutics and Pharmacodynamics, Chicago, IL | 01/2002 |
| State/Local Invited Seminars/Lectures, University of Maryland Medical School, Baltimore, MD | 12/2001 |
| State/Local Invited Seminars/Lectures, University of Puerto Rico, Mayaguez, PR | 12/2001 |
| State/Local Invited Seminars/Lectures, University of Puerto Rico Medical School, San Juan, PR | 12/2001 |
| State/Local Invited Seminars/Lectures, Brown University Medical School, Providence, RI | 07/2001 |
| State/Local Invited Seminars/Lectures, University of California San Francisco Cancer Center, San Francisco, CA | 05/2001 |
| Regional Invited Seminars/Lectures, Bi-annual Tumor Markers Conference, Santa Barbara, CA | 03/2001 |
| State/Local Invited Seminars/Lectures, University of Texas Medical Center, Department of Molecular Medicine, San Antonio, TX | 02/2001 |
| State/Local Invited Seminars/Lectures, Cleveland Clinic Cancer Center, Cleveland, OH | 12/2000 |
| State/Local Invited Seminars/Lectures, University of Minnesota, Department of Pharmacology, Minneapolis, MN | 11/2000 |
| State/Local Invited Seminars/Lectures, University of Wisconsin Medical School, Cancer Center, Madison, WI | 11/2000 |
| State/Local Invited Seminars/Lectures, University of North Dakota, School of Medicine, Department of Biochemistry, Fargo, ND | 10/2000 |
| National and International Invited Seminars/Lectures, Session Chair, Ovarian Cancer 2000: Translational Research - Outcomes and Opportunities, Seattle, WA | 09/2000 |
| Regional Invited Seminars/Lectures, First Annual Early Detection Research Network Workshop, Chicago, IL | 09/2000 |
| National and International Invited Seminars/Lectures, NCI Workshop on Ovarian Cancer Screening, NCI, Bethesda, MD | 09/2000 |
| State/Local Invited Seminars/Lectures, Northwestern University Medical School, Department of Pharmacology, Chicago, IL | 09/2000 |
| State/Local Invited Seminars/Lectures, Washington University, Department of Obstetrics and Gynecology, St Louis, MO | 08/2000 |
| State/Local Invited Seminars/Lectures, Fred Hutchinson Cancer Center, Seattle, WA | 07/2000 |
| State/Local Invited Seminars/Lectures, University of Pittsburgh Cancer Center, Pittsburgh, PA | 07/2000 |
| National and International Invited Seminars/Lectures, AACR Mini-symposium, "EGF Receptor Family Tyrosine Kinases", AACR | 04/2000 |
| National and International Invited Seminars/Lectures, AACR Mini-symposium, "HER2 in Breast Cancer and Other Malignancies", AACR | 04/2000 |
| State/Local Invited Seminars/Lectures, Oregon Health Sciences Cancer Center, Portland, OR | 04/2000 |
| Invited Symposia, Society for Gynecologic Investigation Ovarian Cancer Symposium, Chicago, IL | 03/2000 |
| National and International Invited Seminars/Lectures, Ovarian Cancer Prevention Workshop, NCI Division of Cancer Prevention, NCI, San Francisco, CA | 03/2000 |
Honors, Awards, and Recognition
| LouAnn Woodward, M.D. Authentic Leadership Award, Group on Women in Science, University of Mississippi Medical Center | 2021 |
| Outstanding Service Award, University of Mississippi Medical Center Cancer Center and Research Institute | 2020 |
| Outstanding Faculty Member of Year, Medical College of Georgia | 2016 |
| Caught in Act Compassion Award, Medical College of Georgia | 2016 |
| Golden Pen Academic Achievement Award, Medical College of Georgia | 2016 |
| Phi Kappa Phi Honor Society, Medical College of Georgia | 2015 |
| Distinguished Alumni Award, Albert Einstein College of Medicine | 2013 |
| "Soluble Epidermal Growth Factor Receptor Isoforms and Their Uses in Cancer Detection Methods" United States Patent: 8,017,752, Inventors: J. Reiter and N. J. Maihle, USPTO | 2011 |
| "Soluble Epidermal Growth Factor Receptor Isoforms" United States Patent: 7892541, Inventors: N. J. Maihle, A. T. Baron, and J. L. Reiter, USPTO | 2011 |
| "Soluble ErbB3 Methods of Detection and Antibodies" United States Patent: 7744882, Inventors: N. J. Maihle and H. J. Lee, USPTO | 2010 |
| "Soluble ErbB3 and Treatment of Cancer" United States Patent: 7745398, Inventors: N. J. Maihle and H. J. Lee, USPTO | 2010 |
| "Soluble Epidermal Growth Factor Receptor-Like Proteins and Their Uses in Cancer Detection Methods" United States Patent: 7732157, Inventors: A. T. Baron and N. J. Maihle, USPTO | 2010 |
| "Soluble ErbB3 Method of Detection" United States Patent: 7718384, Inventors: N. J. Maihle and H. J. Lee, USPTO | 2010 |
| Innovation Pipeline Award (Most New Patents), Connecticut Technology Council | 2010 |
| "Soluble ErbB3 Receptor Isoforms" United States Patent: 7638303, Inventors: N. J. Maihle and H. J. Lee, USPTO | 2009 |
| "Soluble ErbB3 Receptor Isoforms" United States Patent: 7638302, Inventors: N. J. Maihle and H. Lee, USPTO | 2009 |
| "Methods for Inhibiting Heregulin and Treating Cancer" United States Patent: 7612042, Inventors: N. J. Maihle and H. Lee, USPTO | 2009 |
| Faculty Scholar, Harvard Macy Institute | 2009 |
| "Soluble ErbB3 Receptor Isoforms" United States Patent: 7390632 Inventors: N. J. Maihle and H. Lee, USPTO | 2008 |
| Research & Leadership Innovation Award, Connecticut Technology Council | 2007 |
| Y50K Award (2nd Place Biotechnology), Yale Univ School of Management | 2007 |
| Y2K Award (1st Place Biotechnology), Yale Univ School of Management | 2007 |
| Visiting Professor Scholarship, Pfizer Corporation | 2004 |
| Fellow, Morse Residential College, Yale University | 2003 |
| Senior Women in Medicine Professorship, Yale University | 2003 |
| Eppley Visiting Professor of Oncology, University of Nebraska Medical Center | 2003 |
| Founding Director, Tumor Biology Program, Mayo Clinic | 2001 |
| Excellence in Teaching Award, Mayo Medical School | 2000 |
| Teacher of the Year Award, Mayo Graduate School | 1998 |
| Excellence in Teaching Award, Mayo Medical School | 1995 |
| Business Advisor of the Year Award, INROADS | 1993 |
| AACR Fellowship "Histopathobiology of Neoplasia", AACR | 1990 |
| Postdoctoral Fellowship, USDA | 1988 |
| Florence B. Seibert Scholarship - Postdoctoral Fellowship, AAUW | 1987 |
| NRSA Postdoctoral Fellowship, NIH | 1985 |
| Postdoctoral Fellowship, Muscular Dystrophy Association | 1984 |
| Outstanding Young Women of America Award, Chamber of Commerce | 1983 |
| Board of Regents Scholarship, State of Ohio | 1973 |
| Member Editorial Board, Trends in Cell Biology Journal Club Board (2001-02) | |
| Member Editorial Board, Drug Discovery (1998-2000) | |
| Member Editorial Board, Molecular Genetics & Genomic Medicine (2019-present) |
Professional Membership and Service
| American Chemical Society, Board of Advisors of a Company | 2020 - Present |
| AACR, Member, Laboratory Research Awards Committee (Clowes' Memorial and Outstanding Achievement Awards) (2013-15) | |
| Hormel Research Institute, Member, Scientific Advisory Committee (1999-2000) | |
| California Breast Cancer Research Program, Member, Pathogenesis Committee (2000-01) | |
| University of Maryland School of Medicine, Chair, External Advisory Committee, Pathology Graduate Program (2001) | |
| Ohio Cancer Research Associates, Reviewer, (2001-present) | |
| Pacific Ovarian Cancer Research Consortium External Advisory Board (supported by NCI SPORE award; Dr. N. Urban, PI), Chair, (2001-09; Member, 2011-present) | |
| University of Puerto Rico, Center of Biological Research Excellence (Supported by NIH COBRE award; Dr. Joseph Bonaventura, PI), Member, External Advisory Board (2001-08) | |
| California Breast Cancer Research Program Review Panel, Chair, (2002-04) | |
| Tumor Biology Investment Group (TBIG), Member, (2002-12) | |
| Robert H. Lurie Cancer Center of Northwestern University (Supported by NCI CCSG; Dr. Steven Rosen, PI), Member, External Advisory Committee (2002-04) | |
| HistoRx, Member, Scientific Advisor (2004-05) | |
| Receptor Biologix, Inc., Member, Scientific Advisor (2004-05) | |
| Catalyst Oncology, Member, Scientific Advisory Board (2004-07) | |
| Van Andel Institute Graduate School, Charter Board Member, Board of Directors, (2004-07; re-appointed, 2008-11) | |
| Bexion Pharmaceuticals, Inc, Chair, Scientific Advisory Board (2012-present) | |
| Fox Chase Cancer Center, Ovarian Cancer Program (supported by NCI SPORE Award, Dr. R. Ozols, PI), Member, External Advisory Board (2008) | |
| Maryland Technology Development Technology Transfer Program, Reviewer, (2008 & 2011) | |
| Fox Chase Cancer Center, Ovarian Cancer Program (supported by NCI SPORE Award, Drs. G. Coukos and M. Seiden, Co-PIs), Chair, External Advisory Board (2009-12) | |
| National Priorities Research Program, Qatar National Research Fund, Member, (2010 - present) | |
| M. D. Anderson Cancer Center, Member, External Review Panel, Department of Gynecologic Oncology (2010) | |
| Nevada Cancer Institute, Chair, External Advisory Board (COBRE)(2010-11) | |
| Ovarian Cancer Research Fund, Member, Scientific Review Panel (2011) | |
| Martell Diagnostics, Inc., Member, Scientific Advisory Board (2011 - present) | |
| Loring Life Sciences, Inc., Co-founder and Board Member (2012 - present) | |
| LifeScience Ventures, Ltd., Member, Scientific Advisory Board (2012-13) | |
| Fondazione Cariplo, Milan, Italy, Member, Scientific Advisory Board (2012 - present) | |
| Coalition for the Life Sciences, Member, Advocacy and Public Policy (2005-present) | |
| American Indian Society for Science and Engineering, Member, Scholarship Review Panel (2014) | |
| Biomedical Research Conducted by Young Investigators - Phase I & II; Fondazione Cariplo, Member, Panel Review (2014-19) | |
| Cancer Research UK, Funding Scheme Science Committee, Multidisciplinary Project, Member, Review Panel (2015) | |
| Qatar National Research Fund, National Priority Research Program, Member, Review Panel (2015 & 2019) | |
| Marsha Rivkin, Member, Scientific Reviewer, Rivkin Center for Ovarian Cancer Research Grants Program (2016-19) | |
| NIH, Member, NIH-sponsored NRMN Group Mentor (National Research Mentoring Network) - Grant Writing Coach - U.S. Southeast Region (2016-present) | |
| 2017 Annual World Congress on Biomarkers & Clinical Research, Member, Organizing Committee | |
| University of Pittsburgh Medical Center, Member, Ovarian Cancer and High-Risk Women (University of Pittsburgh Medical Center) (2001-02) | |
| Marsha Rivkin, Member, Biennial Marsha Rivkin Center Ovarian Cancer Research Symposia (Seattle, WA) (2003-13) | |
| University of Pittsburgh Medical Center, Member, Ovarian Cancer and High-Risk Women (University of Pittsburgh Medical Center) (2003-2004) | |
| Marsha Rivkin, Member, Think Tank Steering Committee, Marsha Rivkin Center for Ovarian Cancer Research (2008-09) | |
| CABTRAC, Member, (Cancer Biology Training Consortium) 11th Annual Meeting Planning Committee, Pittsburgh, PA (2016) | |
| VA, Reviewer, Merit Review Board for Oncology (1990) | |
| NIH, Member, "Cell Biology and Physiology" Study Section (1991) | |
| VA, Member, "Career Development Program" Review Panel (1991) | |
| NSF, Member, (EPSCoR Program) Review Panel (1992) | |
| NIH, Member, GCRC Site Visit Team (Cedars-Sinai Medical Center) (1993) | |
| NIH, Member, "Cell Biology & Physiology" Study Section (Subcommittee 2) (1993-97) | |
| NCI, Member, Program Project Site Visit Team (UCLA Medical School) (1994) | |
| NIH, Member, GCRC Site Visit Team (University of Texas Medical Center) (1994) | |
| NCI, Member, Cancer Center Site Visit Team (Vanderbilt University Cancer Center) (1995) | |
| NCI, Member, Task Force on Intergroup Tumor Banks (1995) | |
| NCI, Member, Cancer Center Support Grant Review Committee (1995) | |
| NCI, Member, Program Project Site Visit Team (SUNY Stony Brook) (1995) | |
| NCI, Member, Cancer Center Site Visit Team (Norris Cancer Center, Los Angeles, CA) (1995) | |
| NCI, Member, Cancer Center Support Grant Review Committee (1995) | |
| NCI, Member, Cancer Center Support Grant Review Committee (1996) | |
| FDA, Member, Site Visit Team (Laboratory of Cell Biology, Division of Cytokine Biology) (1996) | |
| NCI, Member, Cancer Center Site Visit Team (Univ. of Iowa) (1996) | |
| NCI, Member, Program Project Site Visit Team (M.D. Anderson Cancer Center) (1997) | |
| NCI, Member, Cancer Center Site Visit Team (Kaplan Cancer Center, NY) (1998) | |
| NCI, Member, NCI and Society of Gynecologic Oncologists "Ovarian Cancer Strategic Plan and Implementation" Task Force, Bethesda, MD (1998) | |
| NCI, Member, Cancer Center Site Visit Team (Univ. of Virginia Medical School, Charlottesville, VA) (1999) | |
| NCI, Member, Program Project Site Visit Team (Univ. California, San Francisco) (1999) | |
| NIH, Member, Experimental Therapeutics-1 Study Section (1999) | |
| NCI, Member, Ovarian Cancer SPORE Review Panel (1999) | |
| NCI, Member, Cancer Center Site Visit Team (Moffitt Cancer Center, Tampa, FL) (1997, 2000) | |
| NCI, Member, Mouse Models of Human Cancers Consortium: Ovarian Cancer "Think Tank" (San Francisco, CA) (1997-2000) | |
| NCI, Member, Scholars Program Scientific Review Panel (1999-2001) | |
| NIH, Member, Experimental Therapeutics-1 Study Section (2000) | |
| NCI, Member, Cancer Center Site Visit Team (Albert Einstein College Medicine) (1996, 2001) | |
| NCI, Member, Gynecologic Malignancies PRG Panel (2001) | |
| NIH, Member, Center for Scientific Review Study Section Boundaries - Oncological Sciences (2001) | |
| NCI, Member, Breast Cancer SPORE Review Panel (2002) | |
| NCI, Member, Cancer Center Site Visit Team (Irving Cancer Center, Columbia Univ., NY) (2003) | |
| NIH, Chair, Bioengineering Research Partnership Review Panel (SBIR) (2003) | |
| NCI, Board Member, Board of Scientific Counselors (2007-12) | |
| NCI, Member, Cancer Center Site Visit Team (University of Miami Cancer Center, FL) (2008) | |
| NCI, Member, SBIR Technical Emphasis Panel (TEP)-Molecular Diagnostics (2009) | |
| NCI, Chair, Centers of Cancer Nanotechnology Excellence Review Panel (2010) | |
| NCI, Chair, Extramural Review Panel, NCI CCR Laboratory of Mammary Gland Biology (2011) | |
| NCI, Chair, SBIR TEP - Quantitative Tissue Imaging for Clinical Diagnosis and Treatment (2011) | |
| NCI, Chair, Extramural Review Panel, NCI CCR Laboratory of Cell and Cancer Biology (2012) | |
| NCI, Chair, Extramural Review Panel, NCI R21’s (Molecular Diagnostics) (2012) | |
| NCI, Co-chair, NCI Omnibus Review Panel (2012) | |
| NCI, Member, Site Visit Team, Early Detection Research Network, Clinical Validation Center, Fox Chase Cancer Center, Philadelphia, PA (2013) | |
| NCI, Member, Site Visit Team, Early Detection Research Network, Biomarker Development Laboratory, Mass General Hospital, Boston, MA (2013) | |
| NCI, Member, Site Visit Team, Early Detection Research Network, Biomarker Discovery Laboratory, Fred Hutchinson Cancer Center, Seattle, WA (2013) | |
| NCI, Member, Review Panel, Nanotechnology Based Theranostics (U43/44) (2013) | |
| NCI, Member, Executive Steering Committee, NCI-funded (U24) TIES Cancer Research Network (TCRN; 2013-present) | |
| NCI, Member, NCI Review Panel, Provocative Questions (2014) | |
| NCI, Member, NCI Oncology I - IRG (Pre- and Postdoctoral Fellowships Scientific Review Panel) (2015) | |
| NCI, Chair, Review Panel for 'Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE/U54)' (2015) | |
| NCI, Chair, Review Panel for 'Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20)' (2015) | |
| NCI, Co-chair, Review Panel for Oncology 1 Basic Translational Review in Cancer Research (F09)(2017) | |
| NCI, Chair, Review Panel for Clinical and Translational Exploratory/Developmental Studies (R21) (2018) | |
| NCI, Chair, Review Panel for Small Grants Program for Cancer Research (NCI Omnibus R03) (2018) | |
| USAMRDC Prostate Cancer Research Program, Member, Scientific Review Panel (1998) | |
| USAMRDC Ovarian Cancer Research Program, Member, Scientific Review Panel (1999 | |
| USAMRDC Ovarian Cancer Research Program, Chair, Scientific Review Panel (2000-01) | |
| USAMRDC Ovarian Cancer Research Program, Member, Integration Panel (2003-08) | |
| USAMRDC Ovarian Cancer Research Program, Chair, Integration Panel (2006-08) | |
| USAMRDC Ovarian Cancer Research Program, Chair, Scientific Review Panel (2009) | |
| USAMRDC Ovarian Cancer Research Program, Chair, Scientific Review Panel (2011) | |
| USAMRDC Ovarian Cancer Research Program, Co-chair, Award Review Panel (2012) | |
| USAMRDC Ovarian Cancer Research Program, Member, (Ad Hoc), Integration Panel (2013) | |
| USAMRDC Ovarian Cancer Research Program, Member, Award Review Panel (2013) | |
| USAMRDC Ovarian Cancer Research Program, Chair, Scientific Review Panel (2014) | |
| USAMRDC Ovarian Cancer Research Program, Chair, Scientific Review Panel (2015) | |
| USAMRDC Ovarian Cancer Research Program, Chair, Scientific Review Panel (2017) | |
| USAMRDC Ovarian Cancer Research Program, Chair, Scientific Review Panel (2019) | |
| USAMRDC Breast Cancer Research Program, Member, Scientific Review Panel (1997) | |
| USAMRDC Breast Cancer Research Program, Chair, Scientific Review Panel (2000-02) | |
| USAMRDC Breast Cancer Research Program, Chair, Scientific Review Panel (2011) | |
| USAMRDC Breast Cancer Research Program, Chair, Scientific Review Panel (2012) | |
| USAMRDC Breast Cancer Research Program, Co-chair, Award Review Panel (2012) | |
| USAMRDC Breast Cancer Research Program, Chair, Scientific Review Panel (2015) | |
| USAMRDC Breast Cancer Research Program, Member, Scientific Review Panel (05/2019) | |
| USAMRDC Breast Cancer Research Program, Chair, Scientific Genetics Review Panel (2016) | |
| USAMRDC Breast Cancer Research Program, Chair, Scientific Review Panel (01/2017) | |
| USAMRDC Breast Cancer Research Program, Chair, Scientific Review Panel (08/2017) | |
| SGI, Member, Nominations Committee (2004-05) | |
| SGI, Member, Membership Committee (2003-04) | |
| Connecticut Technology Council's Women of Innovation (10th Anniversary Meeting), Member, Nominating Committee (2013-14) | |
| North Central Cancer Treatment Group (NCCTG), Member, Laboratory Correlative Science Committee (1993-98) | |
| North Central Cancer Treatment Group (NCCTG), Member, Executive Committee (1994-98) | |
| National Ovarian Cancer Early Detection Research Network, Founding Co-director, (Dr. David Fishman, Director; Northwestern University) (2003-05) | |
| National Ovarian Cancer Coalition Medical Advisory Board, Member, (2003-07) | |
| GOG, Member, GOG/NCI-Sponsored Gynecologic Cancers Translational Research Retreat (Planning Committee) (2000) | |
| GOG, Chair, Task Force on Industry Relationships (2011-12) | |
| GOG, Member, Member, Committee on Experimental Medicine (Developmental Therapeutics Subcommittee) (2000-present) | |
| AACR, Member, Program Committee, Women in Cancer Research (2001) | |
| AACR, Chair, Charlotte Friend Memorial Award Selection Committee (2002-03) | |
| AACR, Member and Round Table Discussion Leader, Grant Writing Workshop (2002-05 | |
| AACR, Member, Education Committee (2003-05) | |
| AACR, Member, Kirk A. Landon Prize Nominating Committee (2004-05) | |
| AACR, Facilitator, Cancer Research Professional Advancement Workshop (2005) | |
| AACR, Moderator, WICR Professional Leadership Development Workshop (2005) | |
| AACR, Chair, Women in Cancer Research, Nominating Committee (2005-06) | |
| AACR, Chair, Women in Cancer Research (2005-06) | |
| AACR, Chair, Charlotte Friend Memorial Award Selection Committee (2006) | |
| AACR, Co-chair, Grant Writing Workshop (with Dr. William Beck) (2006) | |
| AACR, Member, Executive Committee, Women in Cancer Research (2005-07) | |
| AACR, Member, Education Committee (2008-10) |
Committee Service
| SCHOOL OF MEDICINE-FACULTY APPOINTMENTS, PROMOTIONS AND TENURE, Member | 2021 - Present |
| Biospecimens Access Committee (BIOBANK), Member | 2019 - Present |
| SCHOOL OF MEDICINE-ADMISSIONS INTERVIEW, Member | 2019 - Present |
| Research Cores Advisory Board, Member | 2019 - Present |
| Legislative Alert Committee, American Society for Cell Biology (1990-92), Member | |
| Academic Appointments and Promotions Committee, Department of Biochemistry and Molecular Biology, Mayo Clinic (1989-94), Member | |
| Mayo Medical School, M.D.-Ph.D. Admissions Committee (1989-93), Member | |
| Mayo Graduate School Curriculum Steering Committee (1989-90), Member | |
| Mayo Foundation Equal Opportunities Committee (1989-91), Member | |
| Mayo Foundation Equal Opportunities Committee (1990-91), Vice Chair | |
| Mayo Medical School Faculty Development Committee (1990-91), Member | |
| Mayo Search Committee, Department of Biochemistry, Mayo Clinic (1990-91), Member | |
| Mayo Search Committee, Cancer Biology, Mayo Clinic (1990-91), Member | |
| Mayo Research Committee Task Force, "Celebration for Research" (1990-91), Member | |
| Mayo Molecular Neurosciences Education Committee (1990-93), Member | |
| Pruitt Society Subcommittee (Mayo Foundation Faculty Development) (1991-92), Chair | |
| Mayo Foundation Medical/Industry Relations Committee (1991-95), Member | |
| Mayo Medical School 2nd Year Curriculum Task Force (1991-92), Member | |
| Mayo Task Force on "PCR Technology and Intellectual Property," Mayo Foundation (1991-92), Member | |
| Mayo Basic Science Lectures for "Medical Grand Rounds" (1991-98), Coordinator | |
| Mayo Graduate School Task Force on "Core Curriculum" (1991-92), Member | |
| Task Force on "Minority Summer Student Programs," Mayo Foundation (1991-1992), Chair | |
| Mayo Cancer Center Director's Advisory Committee (1990-97), Member | |
| Mayo Executive Subcommittee of Medical/Industry Relations Committee (1992-95), Member | |
| Personnel Subcommittee of Mayo Research Committee, Mayo Foundation (1992-94), Member | |
| Mayo Minority Student Summer Program, Mayo Graduate School (1992-93), Chair | |
| Congressional Liaison Committee of the Joint Steering Committee for Public Policy, American Society for Cell Biology (1992-95), District Coordinator | |
| Mayo Women's Cancer Program, Mayo Cancer Center (1992-98), Founding Co-director | |
| Mayo Foundation Medical/Industry Relations Committee (1993-95), Vice Chair | |
| Mayo Graduate School Education Committee, (1993-95), Member | |
| Mayo Tumor Biology Education Committee (1993-2003), Chair | |
| Mayo Breast Cancer Research Committee (1993-98), Co-Chair | |
| Mayo Radiation Safety/IACUC Task Force, Research Committee (1993), Chair | |
| Mayo Search Committee, Radiation Biology/Oncology (1994-96), Member | |
| Mayo Conflict of Interest Task Force, Mayo Foundation (1994-95), Chair | |
| Congressional Liaison Committee of the Joint Steering Committee for Public Policy, American Society for Cell Biology (1995-2003), Regional Coordinator | |
| Mayo Tumor Biology Training Program, Mayo Clinic (1992-2003), Founding Director | |
| Mayo Cancer Center Clinical Research Committee, Mayo Clinic (1995-97), Member | |
| Mayo Scientific Advisory Board, "Studies of Monoclonal Gammopathies," (NCI-sponsored Program Project, Dr. Robert Kyle, PI; 1995-2003), Chair | |
| Mayo Medical Laboratories Faculty Search Committee (1996-97), Member | |
| Mayo Waiver of Patent Rights Subcommittee (Medical/Industry Relations Committee), Mayo Foundation (1995), Chair | |
| Mayo Scientific Advisory Board, "Glioblastoma/Brain Tumors," (Supported by NCI SPORE award; Dr. Brian O'Neill, PI; Mayo Clinic; 1995-2013), Member | |
| Mayo Search Committee, Oncology Nursing Research (1995), Member | |
| Mayo Search Committee, Staff Scientist, Mayo Clinic Cancer Center (1995-96), Chair | |
| Mayo Search Committee, Molecular Epidemiologist, Health Sciences Research (1997), Member | |
| Mayo Steering Committee, Neuro-Oncology Training Program (1999-2003), Member | |
| Mayo Scientific Advisory Board, "Prostate Cancer Program," (Supported by NCI SPORE award; Dr. Donald J. Tindall, PI; Mayo Clinic; 2000-03), Member | |
| Yale Clinical Investigation Task Force, School of Medicine (2004-2005), Member | |
| Yale Biotechnology and Biopharmaceutical Society (2004-08), Faculty Advisor | |
| Yale Academic Promotions Committee, Department of Obstetrics, Gynecology & Reproductive Sciences (2004-13), Member | |
| Yale Special Committee for the Dean's Office, School of Medicine (2006), Member | |
| Yale Funds and Fellowship Committee, School of Medicine (2005-2008), Member | |
| Yale Center for Clinical Investigation (NIH CTSA-sponsored) Translational Pilot Awards Review Panel (2010), Member | |
| Yale Grantsmanship Workshop Co-Organizer, 'NIH Funding - How to Get It, How to Keep It,' Office of Sponsored Programs (2010-11), Co-organizer | |
| Yale Academic Promotions Committee, Department of Epidemiology, Yale School of Public Health (2010-11), Member | |
| Yale Women's Faculty Forum (2010-13), Member | |
| Yale Provost's Interdepartmental Mentoring Program (2011-13), Member | |
| Yale External Faculty Advisor, (2013-2018), Member | |
| Yale Faculty Advisory Council, Career Network for Science Ph.D.'s at Yale (CNSPY; 2012-2013), Member | |
| Search Committee, Chair position - Biochemistry and Molecular Biology, Medical College of Georgia (2014 - 2015), Co-Chair | |
| Faculty Recruitment Committee, Georgia Cancer Center (2013 - 2018), Member | |
| Steering Committee, Georgia Cancer Center (2013 - 2018, Member | |
| Executive Committee, Georgia Cancer Center (2013 - 2018), Member | |
| Steering Committee, Georgia Cancer Center Integrative Oncology Program (2013 - 2018), Member | |
| Augusta University Provost's 'Vision 2030' Task Force (2013 - 2014), Member | |
| Augusta University Center for Undergraduate Research & Scholarship Steering Committee (2014 - 2018), Member | |
| Augusta University Faculty Development Coordinating Council (2014 - 2018), Member | |
| Augusta University Provost's Academic Mission Strategic Planning Focus Group (2014), Member | |
| Augusta University Biospecimen Tissue Use and Procurement Review Committee (2015 - 2018), Member | |
| Augusta University Cancer Center Promotion and Tenure Appointments Committee (2015 - 2018), Member | |
| Augusta University Teaching Effectiveness Task Force (2015), Member | |
| Augusta University Faculty Development Subcommittee, University Faculty Senate (2015), Vice Chair | |
| American Cancer Society Institutional Research Grant Review Panel (2015 - 2018), Co-Chair | |
| Augusta University Program Review Panel, Clinical Translational Science Program (2015 - 2018), Member | |
| Augusta University Faculty Mentorship Board, 'Arsenal' - An AU Undergraduate Research Journal (2015 - 2018), Member | |
| Augusta University Executive Committee, MCG Faculty Senate (2015 - 2018), Member | |
| Augusta University Georgia Eminent Faculty Scholar Search Committee (2015 - 2018), Member | |
| Augusta University Office of Leadership Development Faculty Council (2015 - 2018), Member | |
| Augusta University Biochemistry and Cancer Biology Training Program Steering Committee (2016 - 2018), Member | |
| Augusta University Georgia Regents Award Nomination Committee (2016 - 2018), Member | |
| Augusta University Provost's Research Strategic Focus Planning Committee (2016 - 2018), Member | |
| Augusta University Faculty Development Subcommittee, University Faculty Senate (2016 - 2017; member, 2016 - 2018), Chair | |
| Augusta University Office of Faculty Development Awards Committee (2016 - 2017), Member | |
| Augusta University Internal Advisory Board, Institute of Prevention and Public Health (2017 - 2018), Member | |
| Augusta University Bioethics Committee (2017 - 2018), Member | |
| Augusta University Search Committee, Institute of Prevention and Public Health (2017 - 2018), Member | |
| Augusta University Research Institute Board (2017 - 2018), Board Member |
Community Service
| Hope Lodge - fundraiser, Member Org Committee | 02/2006 - 12/2006 |
| Ronald McDonald House - fundraiser, Chair | 03/2005 - 10/2005 |
| National Ovarian Cancer Coalition Medical Advisory Board, Member | 2003 - 12/2006 |
| Girl Scouts of USA, Volunteer | 06/2000 - 05/2001 |
| Girl Scouts of USA, Troop Leader | 06/1999 - 05/2000 |
Teaching Experience
| CMB 744, Graduate, Course, Lecturer, Cellular Biochemistry | Spring 2021 - 2021 |
Directed Student Learning
| Research Advisor, Advised: Lindsay Turner | 2021 - Present |
| Research Advisor, Advised: Martin McCandless | 2020 - Present |
| Research Advisor, Advised: Maris Hardee | 2020 - Present |
| Preceptor, TBD Advised: Melissa Robinson | 2019 - 2012 |
| Undergraduate Honors Thesis, Advised: Tim Malik, Elsie Sowah, Songmin Song, Sejal Hathi, Ka Ian Lio, Peter Shindler, Kristy Webster, Erin Mulvihill, Nneoma Nwachuka, Lindsey Greene, Maureen Braun, Jessica Colon, Giselle Roman, Holli Heffner, Brandi Freeman, Amel Dudakovic, Megan Kasperbauer, Erin Mulvihill, Angela Wheeler-McCleary, Liz Ping Ng, Julie Havlovic, Adam Sakhitab, Emily Brandl-Salutz, Ellen Anderson, Evan Brutinel, Corrie Klopcic, Courtney Lovejoy, Jaime Darce, Lisa Lenertz, Emily Ward, Erin Wes Swingley, Amil Gatza, Elena Frank, Katherine Iossi, Gaurav Khanna, Elis Suichies, Carl Sherman, Thomas Ehrich, Laura Sikkink, Richard Ashley, Andrea Lampland, Debra Teo, Paul Thomas, Elizabeth Coons, Maureen Alt, Tonia Crossley, Shari Meeker, Wendy Lipworth, Jennifer Peoples, Irette Patterson, Tracey Martin, Kathryn Johnson, Judy Heddens, Ravi Kanagala | |
| Master's Thesis Committee Chair, Advised: Kindrea Myles, Tayf Badri, Jacqueline Lafky, Andrew Danielsen, Ayfel Kerimo, William Sullivan, Dane Mathiesen, Karen Showalter | |
| Research Advisor, Advised: Ryan Goetz, Blake Vander Wood, Mojun Zhu, Aletta Houwink, Marianela Perez, Jessica Faupel-Badger, Jonathan Hoyne, Julie Boerner, Margaret Adelsman, Inder Sehgal, Ruben Mesa |
Fellows supervised
| Cancer Research - UMMC, Research Advisor, 45 fellows supervised | 07/2019 - 06/2022 |
| Cancer Research, Post-Doc Advisor, 0 fellows supervised, Maihle Lab |